cellular basis of cancer dr rosemary bass [email protected]
TRANSCRIPT
Cellular Basis of Cancer
Dr Rosemary [email protected]
•Causes of cancer
Last session
•History
•Terminology used to discus cancer
• Incidence Rates
•Cancer Types
•How cells change their nature during cancer progression
•Tumour Growth
Content of this lecture
•Cell Growth / Cell Cycle
•Cancer Progression
•Benign vs Malignant Tumours
• Invasion, Angiogenesis and Metastasis
•Clinical Symptoms and cancer staging
•Diagnosis and Treatment
• cancer also a cellular disease
• mechanisms of normal cell growth control important
• understanding normal cell growth controls may provide therapeutic targets
Cancer and Cell Growth
• cancer is a genetic disease
• cancer studies have also elucidated normal cell growth mechanisms
Mitosis
S Phase
G1G2 G0
Cell Cycle
= major checkpoints
• allow progression to next phase of cell cycle
• cyclins - proteins associated with each phase of cell cycle
• cyclin-dependent kinases (Cdks) - activate or regulate proteins critical for each stage of cell cycle
Cell Cycle Checkpoints
7
Control system co-ordinates cycle
Key control proteins:
Cyclin dependent kinases + cyclins(CDK or CDC)
Cyclins bind CDKs - affect their ability to phosphorylate serine & threonine residues of their substrates
8
Checkpoints
Activity and levels of cyclin/CDK complexes govern these checkpoints
G1/S progressionRb, Myc also important
G2/Mnot completely understood
9
M MG2SG1
Cyclin BR point
Nuclear D1
Cyclin E
Cyclin A
Cyclins ctd.
De-regulation of cyclins associated with cancer
10
Restriction or R point
Deregulation of R point decision making machinery accompanies formation of most types of cancer cells
Commitment to replicate chromosomes, differentiate or enter apoptosis
• growth Factors (GFs)eg. epidermal growth factor (EGF)eg. insulin-like growth factor I (IGF I)
• hormoneseg. thyroid hormones (T3, T4)
• cell anchorage and adhesion
• contact / density inhibition
General Controls of Cell Growth
• nutrient supply (vascularisation)
0.1
1
10
100T
um
ou
r D
iam
eter
(m
m)
Tumour Cell Population Doublings 0 10 20 30 40
108 cells (visible on X-ray)
109 cells (palpable)
1012 cells (patient death)
Tumour Growth Rate
Clonal Growth of Tumour Cells
Clonal Growth of Tumour Cells (2)
new sub-clones may grow
How do you detect cancer?
Cervical dysplasia (1)
• normal cervical squamous epithelium with dysplastic squamous epithelium
normal
dysplastic
http://medlib.med.utah.edu/WebPath
Cervical dysplasia (2)
• normal / dysplastic border in cervical squamous epithelium - cells become more disorderly
norm
aldysplastic
http://medlib.med.utah.edu/WebPath
Cervical neoplasiaN
eosplastic infiltration
http://medlib.med.utah.edu/WebPath
• microscopic appearance of cervical neoplasia
• the neoplasm is infiltrating the underlying cervical stroma
• cancer progression occurs in stages
- dependent on cancer promoters
• benign tumours
Cancer Progression
• malignant tumours
• evidence in some tumours (eg. GI) of progression from benign to malignant
- eg. free radicals / radiation / mutagens
• sub-clones with growth advantage become:
Cancer Progression - Colon
http://www.eurogene.org/etext/cancgen/img/Fodde2/image003.jpg
Benign Malignant
•mitoses few, normal many, abnormal
Benign vs Malignant - Rapid Growth
•nuclei normal large, irregular
•necrosis/ never extensivehaemorrhage
Benign Malignant
•morphology close to variable normal poor
Benign vs Malignant (2) - Differentiation
• function often retained, lost retained or abnormal
products
Benign Malignant
•capsule often intact missing broken
Benign vs Malignant (3) - Boundary
• invasion absent (v. rare) frequent
•metastasis never frequent
• expanding tumour able to grow into tissue spaces and cavities
Invasion
• malignant tumours invade normal tissues
http://www.ma.hw.ac.uk/~jas/researchinterests/cancerinvasion.html
normal cervix
cervical carcinoma
invasive process beginning
• understanding molecular mechanisms of cancer progression
most cancer deaths caused by metastatic tumours
• understanding of molecular mechanisms involved in metastasis important
Discovering New Treatments for Cancer
• understanding molecular mechanisms of cancer initiation
depends upon:
Invasion and Metastasis
• tumour cell produces enzymes / growth factors
Steps in Metastasis
• most steps are active processes
• similar to normal tissue modelling / wound healing
enzymesinhibitor proteins
growth factors
• invasion of surrounding tissue + invasion of blood or lymph vessel
Steps in Metastasis
• cell detachment from tumour mass
- lectins- cadhedrins
Important Proteins in Metastasis
• cell Adhesion Molecules (CAMs)
• extracellular Matrix (ECM) proteins
- collagen, fibronectin etc interact with- integrins on cell surface
• all involved in normal tissue organisation / stability
• interacting proteins must be overcome / digested by metastatic cancer cell
Steps in Metastasis
• survival of conditions in blood or lymph
• most cells die after a few hours due to:
- mechanical stress- lack of essential nutrients- high oxygen toxicity- destruction by immune cells
Steps in Metastasis
• attachment to endothelial cells in capillaries at remote site
• extravasation of tumour cell through vessel wall
Extravasation
- metalloproteinases- cathepsins etc
Important Proteins in Metastasis (2)
• proteolytic enzymes
• new growth stimulators
- growth factors (+ receptors)- hormones
• stimulators of vascularisation
- more growth factors (eg. GF stimulates capillary growth)
Steps in Metastasis
• growth / survival as secondary tumour
• stimulation of new blood supply
Primary Common Sites of Tumour Metastasis
•gastrointestinal livercarcinoma
Typical Metastatic Spread Patterns
•melanoma liver, brain, bowel
•prostatic carcinoma bone
•small-cell lung brain, liver, carcinoma bone marrow
•breast bone, brain, liver, carcinoma adrenal, lung
Angiogenesis
http://www.angio.org/img/cascade_image.jpg
Angiogenesis Steps
1. angiogenic growth factors (GFs) diffuse into nearby tissues
2. GFs bind to specific receptors on endothelial cells (EC) of nearby blood vessels
3. & 4. endothelial cells activated - produce enzymes that dissolve tiny holes in vessel membrane
5 - 10. ECs proliferate through holes towards tumour, form tubes and loops - become stabilised by smooth muscle
0.1
1
10
100T
um
ou
r D
iam
eter
(m
m)
Tumour Cell Population Doublings 0 10 20 30 40
108 cells (visible on X-ray)
109 cells (palpable)
1012 cells (patient death)
Tumour Growth Rate
TUMOUR MARKERS: aim to detect tumours as early as possible
Biomarkers
“A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule”
National Cancer Institute
Tumour Markers
Proteins↑↓ regulated in the progression of cancer
Some specific for one type of cancer, others for >1 type
Potential for screening/prognosis/efficacy of treatment
Blood/saliva/urine vs. biopsy
No routine screening in UK
Classes of Tumour Marker
• Oncofetal proteins
- α-fetoprotein germ cell tumours
primary liver cancer
- CA-125 ovarian cancer
- human chorionic choriocarcinoma
gonadotrophin (hCG) teratoma
• Placental Products
- placental alkaline ovarian cancer phosphatase testicular cancer
• Ectopic Hormones
- adrenocorticotrophic bronchus carcinoma hormone (ACTH)
- calcitonin thyroid cancer
- prostate-specific prostate cancer
antigen (PSA)
• Tissue-specific Antigens
- thyroglobulin thyroid cancer
Classes of Tumour Marker
• Enzymes
- alkaline phosphatase osteosarcoma
- prostatic acid prostate cancer phosphatase
- IgG IgA IgD IgE myeloma
• Immunoglobulins
- Bence-Jones protein myeloma (free κ and λ chains)
- lactic dehydrogenase neroblastoma
Classes of Tumour Marker
Cancer Treatment
• surgery
- principal treatment
- effective local control
- best before tumour spread
- invasive
- may involve risky procedures
http://www.cooperhealth.org/content/MinSurg_Cancer.asp
Cancer Treatment
• Chemotherapy
- body-wide drug delivery
- potential to eliminate metastatic cells
- damaging effects on healthy cells
http://www.ucsf.edu/dpsl/chemo.html
Cancer Treatment
• Radiotherapy
- effective local control
- whole body radiotherapy possible (eg. for lymphomas)
- often used to reduce tumour size prior to surgery
http://www.hnsaonline.com/iort.htm
Radiotherapy
• External Beam
- X-rays from linear accelerator
• Radioactive Implants
- gives very high local dose
- pellets or needles of Yttrium-90
- γ rays from radio-cobalt
http://www.ncrc.ac.yu/onkoeng/odelenja/images/
News Flash!
• doses ~500000 times greater than for medical imaging
Effects of Radiotherapy
• both methods use ionising radiation
• cause many double-strand breaks in DNA
• cells cannot repair DNA and die
• normal cells often recover more quickly than tumour cells
100% cure rare - data shown as 5-year survival
• highly variable, vague or none
• early medical attention improves prognosis
• general symptoms - 1 or more of:
Clinical Symptoms of Cancer
- weakness- breathlessness- weight loss- bleeding- pain (when tumour presses on nerves,
internal organs or erodes bone)
• lump detectable if tumour on or near surface
• clinical investigations:
Clinical Symptoms of Cancer
- physical examination- imaging:
radiography CT (computerised tomography) ultrasound radioisotope scanning MRI (magnetic resonance imaging)lymphography
- biopsy pathologist
Cancer Staging (TNM) eg. lung cancer
Cancer Staging - Primary Tumour
Tis in situ, non-invasive
T1 small, minimally invasive within primary organ site
T2 larger, locally invasive within the primary organ site
T3 moderate size and/or invasive, spread to adjacent lymph nodes
T4 very large and/or very invasive, metastatic spread to distant organs
Cancer Staging - Lymph Nodes and Metastases
N0 no lymph node involvement
N1 regional lymph node involvement
N2 extensive regional lymph node involvement
N3 distant lymph node involvement
M0 no distant metastases
M1 distant metastases present